Course: Ongoing Citations of a Retracted Study Involving Cardiovascular Disease, Drug Therapy, and Mortality in COVID-19
CME Credits: 1.00
Released: 2021-08-02
In Spring 2020, early during the COVID-19 pandemic, 2 prominent studies that used a database from Surgisphere, a little-known company, were quickly retracted because of concerns about fraudulent data. One study purported to study the safety and efficacy of hydroxychloroquine for treating hospitalized patients with COVID-19. Published online in the Lancet on May 22, 2020, it was retracted on June 13, 2020. As of June 11, 2021, the study had an Altmetric attention score of 23,084. The second study claimed to investigate the association between cardiovascular disease, renin-angiotensin–aldosterone system inhibitor therapy, and COVID-19 outcomes. Published online May 1, 2020, in the New England Journal of Medicine (NEJM), it was retracted on June 4, 2020. As of June 11, 2021, the study had an Altmetric attention score of 3727. We sought to evaluate the association of the widely publicized retraction, with further citations of the NEJM study.
Educational Objective
To identify the key insights or developments described in this article
View Full Course